Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where A Kazda is active.

Publication


Featured researches published by A Kazda.


Critical Care | 2009

Marked increase of procalcitonin after the administration of anti-thymocyte globulin in patients before hematopoietic stem cell transplantation does not indicate sepsis: a prospective study.

Helena Brodska; Tomas Drabek; Karin Malickova; A Kazda; Antonin Vitek; Tomáš Zima; Marketa Markova

IntroductionProcalcitonin (PCT) and C-reactive protein (CRP) are established markers of infection in the general population. In contrast, several studies reported falsely increased PCT levels in patients receiving T-cell antibodies. We evaluated the validity of these markers in patients scheduled for hemopoietic stem cell transplantation receiving anti-thymocyte globulin (ATG) during conditioning. We also assessed renal and liver functions and their relationship to PCT and CRP changes.MethodsTwenty-six patients without clinical signs of infection were prospectively studied. ATG was administered in up to three doses over the course of 5 days. PCT, CRP, white blood cell (WBC) count, urea, creatinine, glomerular filtration rate, bilirubin, alanin amino-transferase (ALT), and gamma-glutamyl transferase (GGT) were assessed daily during ATG administration. Pharyngeal, nose, and rectal swabs and urine samples were cultured twice weekly. Blood cultures were obtained if clinical symptoms of infection were present.ResultsBaseline (BL) levels of both PCT and CRP before ATG administration were normal. WBC count decreased after ATG administration (P = 0.005). One day after ATG administration, both PCT and CRP levels increased significantly, returning to BL levels on day 4. Microbiological results were clinically unremarkable. There was no interrelationship between PCT levels and BL markers of renal or liver functions (P > 0.05 for all comparisons). Bilirubin and GGT were increased on days 2 to 5 and ALT was increased on day 3 (P < 0.05 versus BL). No difference in renal functions was observed. Three patients developed bacterial infection on days 7 to 11 with different dynamics of PCT and CRP. There was no association between the number of ATG doses and PCT levels or between the risk of developing infection and previous PCT levels.ConclusionsATG triggered a marked early surge in PCT and CRP followed by a steady decrease over the course of 3 days. The dynamics of both PCT and CRP were similar and were not associated with infection. PCT levels were independent of renal and liver functions and were not predictive of further infectious complications. A direct effect of ATG on T lymphocytes could be the underlying mechanism. Hepatotoxic effect could be a contributing factor. Neither PCT nor CRP is a useful marker that can identify infection in patients receiving ATG.


Intensive Care Medicine | 2011

High-dose selenium substitution in sepsis: a prospective randomized clinical trial.

Jiri Valenta; Helena Brodska; Tomas Drabek; Jan Hendl; A Kazda


Critical Care | 2007

Effect of high-dose selenium substitution on selected laboratory parameters and prognosis in critically ill patients

Jiri Valenta; Helena Brodska; A Kazda; Zdenek Stach; Jan Hendl; K Pelinkova


Critical Care | 2006

Selenium and its substitution in critically ill patients

A Kazda; Helena Brodska; Jiri Valenta; M Vinglerová; Jan Hendl; Zdenek Stach; I Slabá


Trace Elements and Electrolytes | 2012

Selenium: an important trace element and therapeutic adjunct in critical care

Jiri Valenta; Helena Brodska; Tomas Drabek; Zdenek Stach; Tomáš Zima; A Kazda


Critical Care | 2008

Elevation of procalcitonin in chronic dialysed patients

Helena Brodska; Karin Malickova; A Kazda; J Lachmanova; J Uhrova; Tomáš Zima


Critical Care | 2011

Hypernatremia in neurointensive care: results of a 5-year prospective study

V Spatenkova; A Kazda; P Suchomel


Critical Care | 2010

Sodium dysbalances in neurointensive care: results of a 5-year prospective study

V Spatenkova; A Kazda; P Suchomel


Critical Care | 2009

Hypernatraemia in the neurointensive care unit: central diabetes insipidus and noncentral diabetes insipidus

V Spatenkova; A Kazda; P Suchomel


Critical Care | 2008

N-terminal B-type natriuretic peptide and renal function parameters in cerebral salt wasting syndrome

V Spatenkova; A Kazda; P Skrabalek; P Suchomel

Collaboration


Dive into the A Kazda's collaboration.

Top Co-Authors

Avatar

Helena Brodska

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Jiri Valenta

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Zdenek Stach

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Jan Hendl

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Tomáš Zima

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Karin Malickova

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Tomas Drabek

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar

Antonin Vitek

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

I Slabá

Charles University in Prague

View shared research outputs
Researchain Logo
Decentralizing Knowledge